| Literature DB >> 31159377 |
Zhaotian Cai1, Yabing Ye2, Xuan Wan3, Jun Liu4, Shihui Yang5, Yonghui Xia6, Guangli Li7, Quanguo He8.
Abstract
Various morphologies of iron oxide nanoparticles (Entities:
Keywords: GO; dopamine; morphology-dependent; uric acid; voltammetric detection; α-Fe2O3 nanoparticles
Year: 2019 PMID: 31159377 PMCID: PMC6631868 DOI: 10.3390/nano9060835
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Scheme 1The schematic illustration of meta-ion mediated hydrothermal route for the synthesis of discal, thorhombic, and cubic α-Fe2O3 NPs and possible mechanism for the electrochemical sensing of DA and UA at the d-Fe2O3/GO/GCE.
Figure 1Scanning electron microscopy (SEM) images of α-Fe2O3 NPs with cubic (A), thorhombic (B) and discal (C) morphology, discal α-Fe2O3 NPs/GO nanohybrid (D).
Figure 2X-ray diffraction (XRD) patterns of α-Fe2O3 NPs with cubic (c-Fe2O3), discal (d-Fe2O3), and thorhombic (t-Fe2O3) morphologies.
Figure 3Cyclic voltammetry (CV) (A) and differential pulse voltammetry (DPV) (B) curves of c-Fe2O3, t-Fe2O3, and d-Fe2O3 NPs modified GCEs in 0.1 M PBS (pH = 7) containing 10 μM DA and UA.
Figure 4(A) CVs curves of bare GCE, GO/GCE, d-Fe2O3/GCE and d-Fe2O3/GO/GCE in the 0.5 mM [Fe(CN)6]3−/4−; (B) Nyquist plots of different electrodes for the EIS measurements in the presence of 0.5 mM [Fe(CN)6] 3−/4− (1:1) in 0.1 M KCl. The inset is the magnification of Nyquist plots at the higher frequency region.
Figure 5CVs (A) and DPVs (B) of 10 μM DA and UA (1:1) mixture solution at the bare GCE, GO/GCE, d-Fe2O3/GCE and d-Fe2O3/GO/GCE.
Figure 6(A) DPVs of 10 μM DA and UA (1:1) mixture solution recorded at different pH; (B) Effect of pH on the response anodic peak current of DA and UA; (C) Linear plots of the anodic peak potential of DA and UA against pH.
Figure 7Influence of accumulation time (A) and accumulation potential (B) on the response anodic peak currents of DA and UA.
Figure 8(A) CVs of 10 μM DA and UA (1:1) mixture solution recorded at various scanning rates; (B) Linear relationship between the redox peak current of DA and the square root of scanning rate (v1/2); (C) Linear relationship between the anodic peak current of UA and the square root of scanning rate (v1/2).
Figure 9DPVs on the d-Fe2O3/GO/GCE in 0.1 M PBS (pH 5.65) containing 1 μM UA and various concentrations of DA from 0.04 to 100 μM; The inset (A) represents the linear plot of the anodic peak currents versus the DA concentrations varying from 0.04 to 4 μM; The inset (B) represents the linear plot of the anodic peak currents versus the Napierian logarithm of DA concentrations with DA concentration ranging from 4 to 100 μM.
Figure 10(A) DPVs on the d-Fe2O3/GO/GCE in 0.1 M PBS (pH 5.65) containing 1 μM DA and various concentrations of UA from 0.1 to 100 μM; (B) The linear plot of the anodic peak currents of UA versus the UA concentrations varying from 0.1 to 100 μM.
Figure 11(A) DPVs on the d-Fe2O3/GO/GCE in 0.1 M PBS (pH 5.65) containing different concentrations of DA and UA ranging from 0.02–100 μM; Plots of the anodic peak currents as the function of DA concentrations in the range of 0.02–10 μM (B) and 10–100 μM (C); Plots of the anodic peak currents as the function of UA concentrations in the range of 0.02–10 μM (D) and 10–100 μM (E).
Comparison analytical performance between previous reports and the proposed d-Fe2O3/GO/GCE for the simultaneous detection of DA and UA.
| Electrodes | Methods | Detection Range (μM) | LOD (μM) | Ref. | ||
|---|---|---|---|---|---|---|
| DA | UA | DA | UA | |||
| Au/Cu2O/rGO/GCE | DPV | 10–90 | 100–900 | 3.9 | 6.5 | [ |
| NSG–Fe2O3/GCE | DPV | 0.3–210 | 0.035 | [ | ||
| Pd/RGO/GCE | DPV | 0.45–71 | 6–469.5 | 0.18 | 1.6 | [ |
| Pt/RGO/GCE | DPV | 10–170 | 10–130 | 0.25 | 0.45 | [ |
| ZnO/SPCE | DPV | 0.1–374 | 0.1–169 | 0.004 | 0.00849 | [ |
| Fe3O4/rGO/GCE | DPV | 0.5–100 | 0.12 | [ | ||
| AuPtNPs/S-NS-GR/GCE | DPV | 0.01–400 | 1–1000 | 0.006 | 0.0038 | [ |
| Au–Pt/GO–ERGO | DPV | 0.0682–49,800 | 0.125–82,800 | 0.0207 | 0.0407 | [ |
| Fe2O3/NrGO/GCE | Amperometry | 0.5–340 | 0.49 | [ | ||
| ZnO/PANI/rGO/GCE | DPV | 0.1–90 | 0.5–90 | 0.017 | 0.12 | [ |
| pCu2O NS-rGO/GCE | DPV | 0.05–109 | 1–138 | 0.015 | 0.112 | [ |
| Zn-NiAl LDH/rGO/GCE | DPV | 0.0001–1 | 0.0011–0.95 | 0.0001 | 0.0009 | [ |
| α-Fe2O3@Au-Pd/GCE | SWV | 0.1–1000 | 1–1000 | 0.0000138 | 0.97 | [ |
| d-Fe2O3/GO/GCE | DPV | 0.02–10; | 0.02–10; | 0.0032 | 0.0025 | This work |
Figure 12The anodic peak currents of 1 μM DA and UA in the presence of 100-fold alanine (AL), glutamic acid (GA), ascorbic acid (AA), lysine (LY) and citric acid (CA).
Detection results of DA and UA in human serum and urine samples using d-Fe2O3/GO/GCE.
| Samples a | Detected (μM) | Added (μM) | Found (μM) | RSD (%) | Recovery (%) | |
|---|---|---|---|---|---|---|
| Serum | DA | ND b | 20 | 18.82 | 3.75 | 94.1 |
| 40 | 38.26 | 2.86 | 95.7 | |||
| UA | 20.6 | 20 | 41.76 | 2.75 | 105.8 | |
| 40 | 63.86 | 2.21 | 108.2 | |||
| Urine | DA | ND b | 20 | 21.06 | 4.98 | 105.3 |
| 40 | 42.56 | 3.67 | 106.4 | |||
| UA | 35.24 | 20 | 54.27 | 2.62 | 95.2 | |
| 40 | 74.52 | 1.39 | 98.2 | |||
a The human urine and serum samples were detected at 100-fold and 10-fold dilution, respectively. b Not detected.